Sarah McCammon
๐ค SpeakerAppearances Over Time
Podcast Appearances
Today's episode of Up First was edited by Peter Granitz, Emily Kopp, Miguel Macias, Lisa Thompson, and Alice Wolfley. It was produced by Ziad Butch, Nia Dumas, and Ana Perez. We get engineering support from Josephine Neoni, and our technical director is Carly Strange. Join us again tomorrow.
Today's episode of Up First was edited by Peter Granitz, Emily Kopp, Miguel Macias, Lisa Thompson, and Alice Wolfley. It was produced by Ziad Butch, Nia Dumas, and Ana Perez. We get engineering support from Josephine Neoni, and our technical director is Carly Strange. Join us again tomorrow.
Today's episode of Up First was edited by Peter Granitz, Emily Kopp, Miguel Macias, Lisa Thompson, and Alice Wolfley. It was produced by Ziad Butch, Nia Dumas, and Ana Perez. We get engineering support from Josephine Neoni, and our technical director is Carly Strange. Join us again tomorrow.
Yeah, so the NIH has funded hundreds of different kinds of studies on COVID, but just eight of those studies have been clinical trials looking at possible treatments, and patient advocacy groups say this pace is just way too slow.
Yeah, so the NIH has funded hundreds of different kinds of studies on COVID, but just eight of those studies have been clinical trials looking at possible treatments, and patient advocacy groups say this pace is just way too slow.
Yeah, so the NIH has funded hundreds of different kinds of studies on COVID, but just eight of those studies have been clinical trials looking at possible treatments, and patient advocacy groups say this pace is just way too slow.
And also they feel that there's been too much focus in trying to understand why people get sick with long COVID, but not enough attention on trying to relieve their suffering, helping them feel better. And somebody who I've talked to a lot about this is someone named Megan Stone, who is the executive director of the Long COVID Campaign.
And also they feel that there's been too much focus in trying to understand why people get sick with long COVID, but not enough attention on trying to relieve their suffering, helping them feel better. And somebody who I've talked to a lot about this is someone named Megan Stone, who is the executive director of the Long COVID Campaign.
And also they feel that there's been too much focus in trying to understand why people get sick with long COVID, but not enough attention on trying to relieve their suffering, helping them feel better. And somebody who I've talked to a lot about this is someone named Megan Stone, who is the executive director of the Long COVID Campaign.
Also, I'll note, Asma, that an estimated 17 million adults in the U.S. have long COVID, and that means many of them are unable to work or care for their families. And that is why some consider the COVID pandemic a mass disabling event. So, Sarah, what does the NIH say about these criticisms?
Also, I'll note, Asma, that an estimated 17 million adults in the U.S. have long COVID, and that means many of them are unable to work or care for their families. And that is why some consider the COVID pandemic a mass disabling event. So, Sarah, what does the NIH say about these criticisms?
Also, I'll note, Asma, that an estimated 17 million adults in the U.S. have long COVID, and that means many of them are unable to work or care for their families. And that is why some consider the COVID pandemic a mass disabling event. So, Sarah, what does the NIH say about these criticisms?
Well, the agency agrees that there is a real urgency to find treatments, but they told me that scientists need a solid understanding of the underlying biology of long COVID, which is a complicated disease that can damage nearly every organ system. And researchers have learned a lot. For example, one NIH-funded study found that people are less likely to get long COVID if they've been vaccinated.
Well, the agency agrees that there is a real urgency to find treatments, but they told me that scientists need a solid understanding of the underlying biology of long COVID, which is a complicated disease that can damage nearly every organ system. And researchers have learned a lot. For example, one NIH-funded study found that people are less likely to get long COVID if they've been vaccinated.
Well, the agency agrees that there is a real urgency to find treatments, but they told me that scientists need a solid understanding of the underlying biology of long COVID, which is a complicated disease that can damage nearly every organ system. And researchers have learned a lot. For example, one NIH-funded study found that people are less likely to get long COVID if they've been vaccinated.
And I talked to one NIH-funded researcher, Dr. Leora Horowitz. She's at NYU. And she told me that, you know, you have to remember we're only five years into this pandemic. And there is real concern that jumping into clinical trials too soon might not be safe. It could waste money. It could waste time.
And I talked to one NIH-funded researcher, Dr. Leora Horowitz. She's at NYU. And she told me that, you know, you have to remember we're only five years into this pandemic. And there is real concern that jumping into clinical trials too soon might not be safe. It could waste money. It could waste time.
And I talked to one NIH-funded researcher, Dr. Leora Horowitz. She's at NYU. And she told me that, you know, you have to remember we're only five years into this pandemic. And there is real concern that jumping into clinical trials too soon might not be safe. It could waste money. It could waste time.
But it is also true that so far, we still don't have any FDA-approved drugs or devices or any therapies specifically for long COVID.
But it is also true that so far, we still don't have any FDA-approved drugs or devices or any therapies specifically for long COVID.